Skip to main content
Top

Drugs

Issue 5/2007

Content (12 Articles)

Drospirenone for Oral Contraception and Hormone Replacement Therapy

  • Current Opinion

Apurva Motivala, Bertram Pitt

Oral Vinorelbine

  • Leading Article

Matti S. Aapro, Pierfranco Conte, Emilio Esteban González, Véronique Trillet-Lenoir

Botulinum Neurotoxin Type A Free of Complexing Proteins (XEOMIN®) in Focal Dystonia

  • Leading Article

Wolfgang H. Jost, Jörg Blümel, Susanne Grafe

Optimal Management Strategies for Chronic Iron Overload

  • Therapy In Practice

James C. Barton

Induction of Anaesthesia

  • Review Article

Nathalie Nathan, Isabelle Odin

Pharmacological Neuroprotection for Glaucoma

  • Review Article

Glyn Chidlow, John P. M. Wood, Robert J. Casson

Sitaxentan

  • Adis Drug Profile

Lesley J. Scott

Sitaxentan in Pulmonary Arterial Hypertension

  • Adis Drug Profile

Steven Kawut

Sitaxentan in Pulmonary Arterial Hypertension

  • Adis Drug Profile

Marius M. Hoeper

Azithromycin Extended Release

  • Adis Drug Evaluation

Tracy Swainston Harrison, Susan J. Keam

Zoledronic Acid

  • Adis Drug Evaluation

Gillian M. Keating, Lesley J. Scott

Imatinib

  • Adis Drug Evaluation

M. Asif A. Siddiqui, Lesley J. Scott

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images